What we’ve learned about GLP-1 drugs so far
The rapid uptake of weight-loss drugs has given scientists a clearer picture of their effects.
From The Times
June 13, 2026

Thanks to the rapid uptake of Ozempic and other weight-loss drugs, scientists now have a clearer picture of their effects, and the challenges that come with taking them.

A collage illustration featuring images of GLP-1 injection pens, a woman lifting weights, a tape measurer graphic, blood platelets and a scan of a human brain.

Alvvino

Here’s what we’ve learned so far. →

MORE FROM WELL

Closeup of green peas, some in open pods, on an off white surface.

Why the humble pea is actually a nutritional powerhouse. →

A transparent cocktail with a slice of lemon peel seen from above. The glass sits on a marble surface.

A new study suggests that even light drinking increases the risk of premature death. →

A small brown-and-white dog curls up on a bed.

Is it bad to sleep with your pet? We asked the experts. →

Essential news and guidance to live your healthiest life.

Sign up for the Well newsletter.

Essential news and guidance to live your healthiest life.

Get it in your inbox

If you received this newsletter from someone else, subscribe here.

Need help? Review our newsletter help page or contact us for assistance.

You received this message because you signed up for updates from The New York Times.

To stop receiving From The Times, unsubscribe. To opt out of other promotional emails from The Times, including those regarding The Athletic, manage your email settings.

Subscribe to The Times

Connect with us on:

facebookxinstagramwhatsapp

Change Your EmailPrivacy PolicyContact UsCalifornia Notices

Zeta LogoAdChoices Logo

The New York Times Company. 620 Eighth Avenue New York, NY 10018